BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17425475)

  • 1. Chemotherapy for advanced gastric cancer: across the years for a standard of care.
    Scartozzi M; Galizia E; Verdecchia L; Berardi R; Antognoli S; Chiorrini S; Cascinu S
    Expert Opin Pharmacother; 2007 Apr; 8(6):797-808. PubMed ID: 17425475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer. Treatment of advanced disease and new drugs.
    Caponigro F; Facchini G; Nasti G; Iaffaioli RV
    Front Biosci; 2005 Sep; 10():3122-6. PubMed ID: 15970566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel in the treatment of gastric cancer.
    Thuss-Patience PC; Kretzschmar A; Reichardt P
    Future Oncol; 2006 Oct; 2(5):603-20. PubMed ID: 17026452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of advanced gastric cancer: new findings on the activity of the taxanes.
    Van Cutsem E
    Oncologist; 2004; 9 Suppl 2():9-15. PubMed ID: 15161986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine for the treatment of advanced gastric cancer.
    Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative chemotherapy for advanced gastric cancer.
    Wöhrer SS; Raderer M; Hejna M
    Ann Oncol; 2004 Nov; 15(11):1585-95. PubMed ID: 15520058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of gastric cancer.
    Schipper DL; Wagener DJ
    Anticancer Drugs; 1996 Feb; 7(2):137-49. PubMed ID: 8740718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Available options in chemotherapy for advanced gastric cancer: the current developments in Japan.
    Koizumi W
    Expert Opin Pharmacother; 2005 Feb; 6(2):225-31. PubMed ID: 15757419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
    Pozzo C; Barone C
    Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment of gastric cancer.
    Dickson JL; Cunningham D
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):255-63. PubMed ID: 15195888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and future prospects of chemotherapy for metastatic gastric cancer: a review.
    Ohtsu A
    Gastric Cancer; 2005; 8(2):95-102. PubMed ID: 15864716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
    Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis.
    Duo-Ji MM; Ci-Ren BS; Long ZW; Zhang XH; Luo DL
    Oncotarget; 2017 Jun; 8(23):37896-37911. PubMed ID: 28099947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer.
    Bilici A; Selcukbiricik F; Demir N; Oven Ustaalioglu BB; Dikilitas M; Yildiz O
    Asian Pac J Cancer Prev; 2014; 15(20):8661-6. PubMed ID: 25374186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].
    Ohtsu A; Yoshida S; Miyata Y; Shimada Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):444-50. PubMed ID: 7887636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
    Kawamoto Y; Komatsu Y; Yuki S; Sawada K; Muranaka T; Harada K; Nakatsumi H; Fukushima H; Ishiguro A; Dazai M; Hatanaka K; Nakamura M; Iwanaga I; Uebayashi M; Sogabe S; Kobayashi Y; Miyagishima T; Ono K; Sakamoto N; Sakata Y
    BMC Cancer; 2017 Dec; 17(1):837. PubMed ID: 29221445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future treatment options with capecitabine in solid tumours.
    Wilke H
    Eur J Cancer; 2002 Feb; 38 Suppl 2():21-5. PubMed ID: 11841932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of gastric cancer--a review of clinical trials in Japan].
    Sato A; Ito T; Tomita T; Nakamura A; Taguchi S
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1522-31. PubMed ID: 12355938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies.
    Sparano JA
    Semin Oncol; 1998 Dec; 25(6 Suppl 13):10-5. PubMed ID: 9865686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.